The evolution of tuberculosis virulence

Bulletin of Mathematical Biology

Volumn 71, Issue 5, 2009, Pages 1073-1088

  Basu, Sanjay ^a   Galvani, Alison P ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug resistance; Evolution; HIV; Tuberculosis; Virulence

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; EVOLUTION; GENETIC SELECTION; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATHEMATICAL PHENOMENA; MICROBIOLOGY; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; TUBERCULOSIS; VIRULENCE;

DRUG RESISTANCE, BACTERIAL; EVOLUTION; HIV INFECTIONS; HUMANS; MATHEMATICAL CONCEPTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SELECTION (GENETICS); TUBERCULOSIS; VIRULENCE;

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 67651111729     PISSN: 00928240     EISSN: 15229602     Source Type: Journal    
DOI: 10.1007/s11538-009-9394-x     Document Type: Article

References (53)

1. Anderson, R.M., May, R.M., 1991. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press, London.
2. S. Basu 2007 Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study Lancet 370 9597 1500 1507
3. S.M. Blower T. Chou 2004 Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance Nat. Med. 10 10 1111 1116
4. S.M. Blower J.L. Gerberding 1998 Understanding, predicting and controlling the emergence of drug-resistant tuberculosis: a theoretical framework J. Mol. Med. 76 9 624 636
5. S.M. Blower 1995 The intrinsic transmission dynamics of tuberculosis epidemics Nat. Med. 1 8 815 821
6. M. Boots A. Sasaki 1999 'Small worlds' and the evolution of virulence: infection occurs locally and at a distance Proc. Biol. Sci. 266 1933 1938
7. H.J. Bremerman H.R. Thieme 1989 A competitive-exclusion principle for pathogen virulence J. Math. Biol. 27 179 190
8. K.G. Castro S.W. Dooley 1993 Mycobacterium tuberculosis transmission in healthcare settings: is it influenced by coinfection with human immunodeficiency virus? Infect. Control. Hosp. Epidemiol. 14 2 65 66
9. T. Cohen M. Murray 2004 Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness Nat. Med. 10 10 1117 1121
10. Cohen, T. et al., 2006. Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission. J. R. Soc. Interface.
11. E.L. Corbett 2006 Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment Lancet 367 9514 926 937
12. Crofton, J., Horne, N., Miller, F., 1999. Pulmonary tuberculosis in adults. In: Clinical Tuberculosis. MacMillan, London.
13. M. Cruciani 2001 The impact of human immunodeficiency virus type 1 on infectiousness of tuberculosis: a meta-analysis Clin. Infect. Dis. 33 11 1922 1930
14. C.L. Daley 1992 An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms N. Engl. J. Med. 326 4 231 235
15. G. Di Perri 1989 Nosocomial epidemic of active tuberculosis among HIV-infected patients Lancet 2 8678-8679 1502-1504
16. C. Dye M.A. Espinal 2001 Will tuberculosis become resistant to all antibiotics? Proc. Biol. Sci. 268 1462 45 52
17. C. Dye B.G. Williams 2000 Criteria for the control of drug-resistant tuberculosis Proc. Natl. Acad. Sci. USA 97 14 8180 8185
18. C. Dye 1998 Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy Lancet 352 9144 1886 1891
19. C. Dye 2002 Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis Science 295 5562 2042 2046
20. D. Ebert J.J. Bull 2003 Challenging the trade-off model for the evolution of virulence: is virulence management feasible? Trends Microbiol. 11 1 15 20
21. ECA 2006 Beijing/W genotype mycobacterium tuberculosis and drug resistance Emerg. Infect. Dis. 12 5 736 743
22. B.R. Edlin 1992 An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome N. Engl. J. Med. 326 23 1514 1521
23. J.D. Ernst G. Trevejo-Nunez N. Banaiee 2007 Genomics and the evolution, pathogenesis, and diagnosis of tuberculosis J. Clin. Invest. 117 7 1738 1745
24. A.R. Escombe 2007 The detection of airborne transmission of tuberculosis from HIV-infected patients, using an in vivo air sampling model Clin. Infect. Dis. 44 10 1349 1357
25. I. Eshel 1983 Evolutionary and continuous stability J. Theor. Biol. 103 99 111
26. Z. Feng C. Castillo-Chavez A.F. Capurro 2000 A model for tuberculosis with exogenous reinfection Theor. Popul. Biol. 57 3 235 247
27. G. Friedland 2007 Tuberculosis, drug resistance and HIV/AIDS: a triple threat Curr. Infect. Dis. Rep. 9 3 252 261
28. G. Friedland G.J. Churchyard E. Nardell 2007 Tuberculosis and HIV coinfection: current state of knowledge and research priorities J. Infect. Dis. 196 1 S1 S3
29. N.R. Gandhi 2006 Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa Lancet 368 9547 1575 1580
30. W.A. Githui 2004 Identification of MDR-TB Beijing/W and other mycobacterium tuberculosis genotypes in Nairobi Kenya. Int. J. Tuberc. Lung. Dis. 8 3 352 360
31. Health Systems Trust, 2007. HIV Prevalence. HST, Durban.
32. E. Keeler 2006 Reducing the global burden of tuberculosis: the contribution of improved diagnostics Nature 444 1 49 57
33. Keeling, M.J., Rohani, P., 2007. Modeling Infectious Diseases in Humans and Animals. Princeton University Press, Princeton.
34. N.T. Lan 2003 Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse Vietnam. Emerg. Infect. Dis. 9 12 1633 1635
35. Lawn, S.D. et al., 2007. Early mortality among patients with HIV-associated TB in Africa: implications for the time to initiate ART. In: 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles.
36. B.R. Levin 1996 The evolution and maintenance of virulence in microparasites Emerg. Infect. Dis. 2 2 93 102
37. M. Lipsitch M.B. Murray 2003 Multiple equilibria: tuberculosis transmission require unrealistic assumptions Theor. Popul. Biol. 63 2 169 170
38. N.H. Mann 2003 Marine ecosystems: bacterial photosynthesis genes in a virus Nature 424 6950 741
39. D.A. Moore 2006 Microscopic-observation drug-susceptibility assay for the diagnosis of TB N. Engl. J. Med. 355 15 1539 1550
40. Otto, S.P., Day, T., 2007. A Biologist's Guide to Mathematical Modeling in Ecology and Evolution. Princeton University Press, Princeton.
41. V. Pillay A.W. Sturm 2007 Evolution of the extensively dRUG-resistant F15/LAM4/KZN strain of mycobacterium tuberculosis in KwaZulu-Natal, South Africa Clin. Infect. Dis. 45 11 1409 1414
42. D.R. Sherman 1996 Compensatory ahpC gene expression in isoniazid-resistant mycobacterium tuberculosis Science 272 5268 1641 1643
43. P.M. Small 1993 Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection N. Engl. J. Med. 328 16 1137 1144
44. J.M. Smith G.R. Price 1973 The logic of animal conflict Nature 246 15 18
45. Special Programme for Tropical Diseases Research, 2006. Diagnostics for Tuberculosis: Global Demand and Market Potential. WHO, Paris.
46. P. van den Driessche J. Watmough 2002 Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission Math. Biosci. 180 29 48
47. B.G. Williams C. Dye 2003 Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS Science 301 5639 1535 1537
48. B.G. Williams 2005 The impact of HIV/AIDS on the control of tuberculosis in India Proc. Natl. Acad. Sci. USA 102 27 9619 9624
49. World Health Organization, 2005. The Impact of HIV on TB in Africa. WHO, Paris.
50. World Health Organization, 2006. Progress on Global Access to HIV Antiretroviral Therapy: A Report on "3 by 5" and beyond. WHO, Paris.
51. World Health Organization, 2007a. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO, Paris.
52. World Health Organization, 2007b. Global Tuberculosis Control-Surveillance, Planning, Financing. WHO, Paris.
53. S. Wright 1931 Evolution in Mendelian populations Genetics 16 97 159